MEDICAL COMPRESSION SYSTEM (D.B.N) LTD. Inactive Instrument
Medical Compression System (D.B.N) Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
MDCL-M
IL0010968902
Healthcare Facilities & Services
| Sales 2022 | 22.66M 5.94M 2.27B | Sales 2023 | 14.41M 3.78M 1.44B | Capitalization | 3.12M 818K 312M |
|---|---|---|---|---|---|
| Net income 2022 | -25M -6.55M -2.5B | Net income 2023 | -9M -2.36M -900M | EV / Sales 2022 | 0.4 x |
| Net cash position 2022 | 925K 242K 92.5M | Net cash position 2023 | 768K 201K 76.8M | EV / Sales 2023 | 0.16 x |
| P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.05% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 19-06-16 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-12-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 22-12-04 |
Locar Gila
BRD | Director/Board Member | 51 | 22-11-28 |
| Director/Board Member | 43 | 22-11-28 |
Medical Compression System DBN Ltd is an Israel-based company active in the medical sector. It is engaged in the research, development, production and marketing of non-invasive and non-medicinal solutions to improve the blood flow processes, using a pneumatic device which places pressure on the limbs by means of compressed air. The technology developed by the Company facilitates reducing the risk of blood clots forming during traumatic and surgical events, and secular diseases. It also completed the development of a pneumatic device for preventing the formation of blood clots in the deep veins system as the result of a trauma or surgical intervention, which is called the ActiveCare DVT.
| 1st Jan change | Capi. | |
|---|---|---|
| +27.84% | 264M | |
| +28.81% | 251M | |
| +48.84% | 193M | |
| +38.04% | 125M | |
| -41.00% | 122M | |
| -28.57% | 121M | |
| +115.91% | 120M | |
| +150.00% | 75.33M | |
| -3.85% | 83.42M |
